Post-authorisation measures: questions and answers
Submitted by Anonymous (not verified) on 27 March 2026 - 13:20
Post-authorisation measures: questions and answers
Template - Application for transfer of marketing authorisation from transferor to transferee - cover letter (human)
Submitted by Anonymous (not verified) on 27 March 2026 - 12:00
Template - Application for transfer of marketing authorisation from transferor to transferee - cover letter (human)
European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure: document with tracked changes
Submitted by Anonymous (not verified) on 27 March 2026 - 12:00
European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure: document with tracked changes
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with tracked changes
Submitted by Anonymous (not verified) on 27 March 2026 - 12:00
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with tracked changes
Transfer of marketing authorisation template - attachment 3
Submitted by Anonymous (not verified) on 27 March 2026 - 12:00
Transfer of marketing authorisation template - attachment 3
European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure
Submitted by Anonymous (not verified) on 27 March 2026 - 12:00
European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
Submitted by Anonymous (not verified) on 27 March 2026 - 12:00
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
New treatment for relapsed extensive-stage small cell lung cancer
Submitted by Anonymous (not verified) on 27 March 2026 - 12:00
New treatment for relapsed extensive-stage small cell lung cancer
Summary of opinion: Tafinlar, 26/03/2026 Positive
Submitted by Anonymous (not verified) on 27 March 2026 - 12:00
Summary of opinion: Tafinlar, 26/03/2026 Positive
Post-authorisation efficacy studies: questions and answers
Submitted by Anonymous (not verified) on 27 March 2026 - 12:00
Post-authorisation efficacy studies: questions and answers